CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 72 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,594,153 | +133.7% | 53,603 | +41.6% | 0.00% | – |
Q2 2023 | $682,020 | +88.3% | 37,848 | +67.9% | 0.00% | – |
Q1 2023 | $362,104 | +24.1% | 22,547 | +41.4% | 0.00% | – |
Q4 2022 | $291,812 | -2.7% | 15,946 | +4.5% | 0.00% | – |
Q3 2022 | $300,000 | +11.5% | 15,261 | +5.8% | 0.00% | – |
Q2 2022 | $269,000 | -14.1% | 14,430 | +1.3% | 0.00% | – |
Q1 2022 | $313,000 | -20.4% | 14,241 | +2.8% | 0.00% | – |
Q4 2021 | $393,000 | +94.6% | 13,851 | +44.6% | 0.00% | – |
Q3 2021 | $202,000 | +110.4% | 9,576 | +88.0% | 0.00% | – |
Q2 2021 | $96,000 | +50.0% | 5,093 | +20.3% | 0.00% | – |
Q1 2021 | $64,000 | +12.3% | 4,235 | +5.7% | 0.00% | – |
Q4 2020 | $57,000 | -9.5% | 4,005 | 0.0% | 0.00% | – |
Q3 2020 | $63,000 | -30.0% | 4,005 | -21.9% | 0.00% | – |
Q2 2020 | $90,000 | +221.4% | 5,129 | +174.0% | 0.00% | – |
Q1 2020 | $28,000 | -48.1% | 1,872 | -17.2% | 0.00% | – |
Q4 2019 | $54,000 | +92.9% | 2,262 | +22.7% | 0.00% | – |
Q3 2019 | $28,000 | -39.1% | 1,843 | 0.0% | 0.00% | – |
Q2 2019 | $46,000 | +39.4% | 1,843 | +26.0% | 0.00% | – |
Q1 2019 | $33,000 | +6.5% | 1,463 | +38.9% | 0.00% | – |
Q4 2018 | $31,000 | +3.3% | 1,053 | 0.0% | 0.00% | – |
Q3 2018 | $30,000 | – | 1,053 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Saturn V Capital Management LP | 623,819 | $11,336,501 | 9.41% |
Finepoint Capital LP | 822,745 | $15,056 | 4.87% |
Bain Capital Life Sciences Investors, LLC | 2,305,558 | $42,192 | 4.72% |
Opaleye Management Inc. | 732,000 | $13,395,600 | 4.66% |
5AM Venture Management, LLC | 862,286 | $15,779,834 | 4.24% |
SPHERA FUNDS MANAGEMENT LTD. | 671,644 | $12,291,085 | 2.64% |
First Light Asset Management, LLC | 1,329,313 | $24,326,428 | 2.26% |
BRAIDWELL LP | 3,469,674 | $63,495,034 | 2.13% |
BVF INC/IL | 2,736,613 | $50,080,018 | 2.11% |
Perceptive Advisors | 4,039,276 | $73,918,751 | 2.08% |